Empagliflozin reduces markers of acute kidney injury in patients with acute decompensated heart failure

Abstract Aims In this prospective, placebo‐controlled, double‐blind, exploratory study, we examined early and more delayed effects of empagliflozin treatment on haemodynamic parameters (primary endpoint: cardiac output) and kidney function including parameters of acute kidney injury (AKI) in patient...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Kirsten Thiele, Matthias Rau, Niels‐Ulrik Korbinian Hartmann, Marcus Möller, Julia Möllmann, Joachim Jankowski, András P. Keszei, Michael Böhm, Jürgen Floege, Nikolaus Marx, Michael Lehrke
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Oxford University Press 2022-08-01
coleção:	ESC Heart Failure
Assuntos:	SGLT2 inhibitors Empagliflozin Acute decompensated heart failure Acute kidney injury Haemodynamic parameters
Acesso em linha:	https://doi.org/10.1002/ehf2.13955
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!